Company intelligence / Profile preview

Feather Weight

Cambridge, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Featherweight is an early-stage biotechnology company focused on developing next-generation therapies for obesity and metabolic diseases. The company operates primarily in stealth mode, leveraging expertise in incretin-based mechanisms to create highly differentiated weight-loss treatments. Its research programs aim to improve upon existing GLP-1 and GIP receptor agonists by optimizing dosing frequency, tolerability, and weight-loss efficacy. Featherweight is part of a growing wave of venture-backed startups seeking to capitalize on the rapidly expanding metabolic health market.

Therapeutic areas: Metabolic DisordersEndocrinology
Modalities: Small moleculePeptidesBiologic
Industry: Biotech

Beyond the preview

Go deeper on Feather Weight.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Feather Weight.

Explore the full profile